KALA - Kala Bio Inc.
0.2939
0.033 11.364%
Share volume: 1,150,828
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$0.26
0.03
0.13%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-06-2024 | 11-12-2024 | 05-14-2025 | 08-08-2025 | 11-19-2025 | |
| Assets | |||||||
| Total Assets | 53.033 M | 61.606 M | 54.079 M | 48.252 M | 36.053 M | 25.021 M | |
| Current Assets | 50.087 M | 58.853 M | 51.279 M | 45.717 M | 33.663 M | 24.274 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 48.478 M | 54.197 M | 49.202 M | 42.222 M | 31.942 M | 21.096 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 714.000 K | 617.000 K | 762.000 K | 695.000 K | 657.000 K | 603.000 K | |
| Other Assets | 2.232 M | 2.136 M | 2.038 M | 1.840 M | 1.733 M | 144.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 53.033 M | 61.606 M | 54.079 M | 48.252 M | 36.053 M | 25.021 M | |
| Total liabilities | 46.372 M | 47.889 M | 47.220 M | 42.544 M | 39.259 M | 33.686 M | |
| Total current liabilities | 11.879 M | 19.190 M | 23.867 M | 22.975 M | 16.016 M | 32.574 M | |
| Accounts Payable | 732.000 K | 665.000 K | 711.000 K | 931.000 K | 658.000 K | 917.000 K | |
| Other liabilities | 5.983 M | 5.867 M | 6.191 M | 4.448 M | 4.457 M | 1.112 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 28.510 M | 22.832 M | 17.162 M | 15.121 M | 18.786 M | 0.000 | |
| Other liabilities | 5.983 M | 5.867 M | 6.191 M | 4.448 M | 4.457 M | 1.112 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 6.661 M | 13.717 M | 6.859 M | 5.708 M | -3.206 M | -8.665 M | |
| Common stock | 647.877 M | 664.512 M | 666.604 M | 682.575 M | 684.816 M | 686.921 M | |
| Retained earnings | -641.216 M | -650.795 M | -659.745 M | -676.867 M | -688.022 M | -695.586 M |